0.25% Bupivacaine Versus a Mixture of 0.25% Bupivacaine and 1.3 % Liposomal Bupivacaine in Patients Undergoing Tka
Clinical trial NCT03303794 · TERMINATED
Trial details
- NCT number
- NCT03303794
- Sponsor
- Montefiore Medical Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2018-06-27
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.